Skin Cancer Home > Proleukin Administration

Proleukin® (aldesleukin) is approved for treating skin or kidney cancer that has spread to other areas of the body (metastasized). Your healthcare provider will administer Proleukin as a slow injection into a vein (intravenous, or IV, infusion). It is given every eight hours for five days, followed by a nine-day break, and then an additional five days of treatment.
Administration of each Proleukin infusion will take about 15 minutes. The specific dosage your healthcare provider prescribes will depend on your weight and how you respond to the drug. Because doses of Proleukin vary for each person, your healthcare provider will need important information on your medical history and any other medications you are taking to help ensure a safe treatment process.
(Click Proleukin Dosage for a closer look at the administration of this chemotherapy drug, including factors that may affect your dosage and considerations to be aware of during treatment.)
Written by/reviewed by:
Last reviewed by: Kristi Monson, PharmD;
Last updated/reviewed:
List of references (click here):



Related Channels

eMedTV Links
Copyright © 2006-2020 Clinaero, Inc.

eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.

This site complies with the HONcode standard for trustworthy health information:
verify here.